No Data
No Data
Express News | Applied DNA Sciences: Received Formal Notification From Nasdaq, Confirming Co Complies With Nasdaq Listing Rule 5550(B)(1)
Maxim Group Maintains Applied DNA Sciences(APDN.US) With Hold Rating
Maxim Group analyst Jason McCarthy maintains $Applied DNA Sciences(APDN.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 24.4% and a total average return of -20.9%
Express News | Applied DNA And Alphazyme Conclude Linea RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement In Linea IVT Platform Economics
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Suffi
Express News | Applied DNA Sciences Partners With GenXys Health Care Systems To Enhance Precision Prescribing With TR8 Pharmacogenomic Test; Aims To Improve Patient Outcomes And Reduce Healthcare Costs Through Data-Driven Genetic Analysis
Applied DNA Partners With GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Partnership Will Aid Physicians in Precision Prescribing Decisions Based on Applied DNA's TR8 Pharmacogenomic (PGx) Test STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (NASD
No Data
eternityawaits : I’m ready!
indecisive Capybara : What u think of vs claiming 2 again ?